• New AI capabilities will help scientists  identify, optimize and validate new molecules
• Additional applications include manufacturing, medical imaging and enterprise AI agents

Abu Dhabi, November. 07, 2025: Eli Lilly and Company (NYSE: LLY) today announced it is building the most powerful supercomputer owned and operated by a pharmaceutical company, in collaboration with NVIDIA. The supercomputer will power an “AI factory,” a specialized computing infrastructure that manages the entire AI lifecycle from data ingestion and training to fine-tuning and high-volume inference.